COVID-19 Impact on Global Clinical Research Organisation (CRO) Market Growth (Status and Outlook) 2020-2025
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Clinical Research Organisation (CRO) Market Size 2015-2025
3 Global Clinical Research Organisation (CRO) by Players
- 3.1 Global Clinical Research Organisation (CRO) Market Size Market Share by Players
- 3.1.1 Global Clinical Research Organisation (CRO) Market Size by Players (2018-2020)
4 Clinical Research Organisation (CRO) by Regions
- 4.1 Clinical Research Organisation (CRO) Market Size by Regions
- 4.2 Americas Clinical Research Organisation (CRO) Market Size Growth
- 4.3 APAC Clinical Research Organisation (CRO) Market Size Growth
- 4.4 Europe Clinical Research Organisation (CRO) Market Size Growth
- 4.5 Middle East & Africa Clinical Research Organisation (CRO) Market Size Growth
5 Americas
- 5.1 Americas Clinical Research Organisation (CRO) Market Size by Countries
- 5.2 Americas Clinical Research Organisation (CRO) Market Size by Type
- 5.3 Americas Clinical Research Organisation (CRO) Market Size by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Clinical Research Organisation (CRO) Market Size by Regions
- 6.2 APAC Clinical Research Organisation (CRO) Market Size by Type
- 6.3 APAC Clinical Research Organisation (CRO) Market Size by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Regions
7 Europe
- 7.1 Europe Clinical Research Organisation (CRO) by Countries
- 7.2 Europe Clinical Research Organisation (CRO) Market Size by Type
- 7.3 Europe Clinical Research Organisation (CRO) Market Size by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Clinical Research Organisation (CRO) by Countries
- 8.2 Middle East & Africa Clinical Research Organisation (CRO) Market Size by Type
- 8.3 Middle East & Africa Clinical Research Organisation (CRO) Market Size by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
10 Global Clinical Research Organisation (CRO) Market Forecast
- 10.1 Global Clinical Research Organisation (CRO) Market Size Forecast (2021-2025)
- 10.2 Global Clinical Research Organisation (CRO) Forecast by Regions
- 10.2.1 Global Clinical Research Organisation (CRO) Forecast by Regions (2021-2025)
11 Key Players Analysis
- 11.1 Charles River Laboratories
- 11.1.1 Company Details
12 Research Findings and Conclusion
According to this study, over the next five years the Clinical Research Organisation (CRO) market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global revenue market share of key companies in Clinical Research Organisation (CRO) business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Clinical Research Organisation (CRO) market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the Clinical Research Organisation (CRO), covering the supply chain analysis, impact assessment to the Clinical Research Organisation (CRO) market size growth rate in several scenarios, and the measures to be undertaken by Clinical Research Organisation (CRO) companies in response to the COVID-19 epidemic.
Segmentation by type: breakdown data from 2015 to 2020 in Section 2.3; and forecast to 2025 in section 10.7.
Small molecules
Biologics
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2025 in section 10.8.
Pharmaceutical Company
Research Institute
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Charles River Laboratories
Reprocell
IQVIA
Domainex
Evotec AG
LabCorp
Aurobindo Pharma
Genscript Biotech
Eurofins Scientific
GVK Biosciences
Sun Pharmaceutical
Vitas Pharma
Sai Ganga Panakeia
Dalton Pharma
Lupin Pharmaceuticals
Jubilant Biosys
WuXi AppTec
Piramal Pharma
NovAliX
Pharmaron Beijing
Porton Pharma
ChemPartner
Asymchem Laboratories
Hangzhou Tigermed
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Clinical Research Organisation (CRO) market size by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Clinical Research Organisation (CRO) market by identifying its various subsegments.
Focuses on the key global Clinical Research Organisation (CRO) players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Clinical Research Organisation (CRO) with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Clinical Research Organisation (CRO) submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.